Results 91 to 100 of about 8,269 (200)
Background: The progression of myelodysplastic neoplasms (MDS) to chronic myelomonocytic leukemia (CMML) has been recognized since a long time. Several works have shown that 4.8% - 20% of patients with MDS may progress to CMML, depending on the criteria ...
Joyce Rico VIDO-MARQUES +5 more
doaj +1 more source
CMML is heterogeneous clinically (a varying degree of dysplastic or proliferative clinical features) and in terms of its molecular pathogenesis. Analysis of the spectrum of genomic lesions in CMML may contribute to understanding of the pathogenesis and ...
Przychodzen, Bartlomiej +27 more
core +1 more source
Clinical management of
Summary Chronic myelomonocytic leukaemias (CMML) are myeloid neoplasms characterized by a sustained increase in monocyte counts in the peripheral blood, accompanied by dysplasia, abnormal proliferation, chromosomal anomalies and somatic mutations of haematopoietic cells. More than 95% of CMML patients harbour somatic mutations.
K. Nachtkamp +3 more
openaire +3 more sources
Background and objectiveChronic myelomonocytic leukemia (CMML) is a malignant clonal disorder characterized by both myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN) features.
Yanquan Liu +8 more
doaj +1 more source
Background: This retrospective cohort study investigates the prognostic significance of genetic mutations in Chronic Myelomonocytic Leukemia (CMML) and their association with treatment responses among patients treated at a single institution, juxtaposed ...
Jing Di +7 more
doaj +1 more source
Chronic myelomonocytic leukemia (CMML) is a relatively rare clonal hematologic disorder with features of myelodysplastic syndrome and myeloproliferative disease. Extramedullary leukemic involvement is rarely a presenting feature of CMML.
Prasun Pudasainee +4 more
doaj +1 more source
Analysis of differentially methylated genes in CMML samples with and without TET2 mutations.
A) Hierarchical cluster analysis based on abnormally methylated genes between CMML samples with TET2 mutations and CMML samples without TET2 mutations.
Jacqueline Boultwood (89560) +16 more
core +1 more source
Key Points Genetically accurate xenografts of CMML are achievable with near 100% frequency in NSGS mice. Robust human engraftment and overt phenotypes of CMML and JMML xenografts here facilitate preclinical therapeutic evaluation in vivo.
Lu, Sydney X +51 more
core +1 more source

